Ligia sells BMRN 62.56: Ligand Pharmaceuticals has Relatively Underperformed its Peers in the Biotechnology Industry (LGND, ALNY, NPSP, BMRN, SGMO)
BioMarin Pharmaceutical (NASDAQ:BMRN) follows with a loss of 2.80% and Sangamo Biosciences (NASDAQ:SGMO) rounds out the bottom five with a loss of 2.53%. Ligand Pharmaceuticals Incorporated develops drugs which regulate hormone activated intracellular ... ...
34 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home